| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| HOCH PH |
Experimentally produced psychoses |
Am J Psychiatry |
1951 |
| Landis C, Clausen J |
Certain effects of mescaline and lysergic acid on psychological functi... |
J. Psychol. |
1954 |
| Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
| EDDY NB, HALBACH H, BRAEN... |
Synthetic substances with morphine-like effect: clinical experience; p... |
Bull World Health Or... |
1957 |
| Smart RG, Bateman K |
Unfavourable reactions of LSD: a review and analysis of the available ... |
Canadian Medical Ass... |
1967 |
| Editorial |
Hallucinations to Order [in News and Views] |
Nature |
1967 |
| Schnoll SH, Vogel WH |
Analysis of street drugs |
N Engl J Med |
1971 |
| Grof S |
LSD and the Cosmic Game: Outline of Psychedelic Cosmology and Ontology |
Journal for the Stud... |
1972 |
| Pascal JP, Vaysse N, Ader... |
The Mechanisms of Functional Vasodilation in the Pancreas : |
Digestion |
1973 |
| Caldwell J, Sever PS |
The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... |
Clin.Pharmacol.Ther. |
1974 |
| Shulgin AT, Helisten C |
Differentiation of PCP, TCP, and a contaminating precursor PCC, by thi... |
Microgram |
1975 |
| Jantz L |
Probleme und Möglochkeiten ambulanter und stationäer Behandlune von Su... |
Therapiewoche |
1976 |
| Hasimoto H, Hayashi M, Na... |
Hyperthermic Effects of D-Lysergic Acid Diethylamide (LSD) and its Der... |
Arch. int. Pharmacod... |
1977 |
| Pardanani JH, McLaughlin ... |
Cactus Alkaloids. XXXVI. Mescaline and related compounds from Trichoce... |
Lloydia |
1977 |
| Winter JC |
Stimulus Properties of Phenethylamine Hallucinogens and Lysergic Acid ... |
J.Pharmacol.Exp.Ther... |
1978 |
| Fanchamps A |
Some Compounds With Hallucinogenic Activity |
Handbook of Experime... |
1978 |
| Keller HH, Burkard WP, Pi... |
Lisuride- and D-LSD-Induced Changes of Monoamine Turnover in the Rat B... |
Advances in Biochemi... |
1978 |
| Shulgin AT |
Chemistry of phenethylamines related to mescaline |
J Psychedelic Drugs |
1979 |
| Mace S |
LSD |
CLINICAL TOXICOLOGY |
1979 |
| Pieri L, Keller HH, Laure... |
Behavioral, Neurochemical, and Electrophysiological Effects of Lisurid... |
Lisuride and Other D... |
1983 |
| Hofmann A, Goodwin DW |
LSD: My Problem Child-- Reflections on Sacred Drugs, Mysticism, and S... |
JAMA |
1983 |
| Strassman RJ |
Adverse reactions to psychedelic drugs. A review of the literature |
J Nerv Ment Dis |
1984 |
| Ziporyn T |
A growing industry and menace: makeshift laboratory's designer drugs |
JAMA |
1986 |
| Dowling GP, McDonough ET ... |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... |
JAMA |
1987 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Duke JD |
Promising Phytomedicinals |
Advances in New Crop... |
1990 |
| Preston A |
Pointing out the Risk |
Nursing Times |
1992 |
| Nevilla GA, Beckstead HD,... |
USP Lysergic Acid Diethylamide Tartrate (LOT 1) Authentic Substance Re... |
Canadian Journal of ... |
1992 |
| Maxwell DL, Polkey MI, He... |
Hyponatraemia and catatonic stupor after taking 'ecstasy' |
BMJ |
1993 |
| McDowell DM, Kleber HD |
MDMA: Its history and pharmacology |
Psychiatric Annals |
1994 |
| Eich E, Pertz H |
Ergot alkaloids as lead structures for differential receptor systems |
Pharmazie |
1994 |
| Henderson GL, Harkey MR, ... |
Metabolism of 4-methylaminorex ('EU4EA') in the rat |
J Anal Toxicol |
1995 |
| Bryden AA, Rothwell PJ, O... |
Urinary retention with misuse of 'ecstasy' |
BMJ |
1995 |
| Freeman RC, French JF |
What is the addicts' grapevine when there's 'bad dope'? An investigati... |
Public Health Rep |
1995 |
| Rezvani K, Kurbaan AS, Br... |
Ecstasy induced pneumomediastinum |
Thorax |
1996 |
| Matthai SM, Davidson DC, ... |
Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted i... |
BMJ |
1996 |
| McKenna DJ |
Plant hallucinogens: springboards for psychotherapeutic drug discovery |
Behav Brain Res |
1996 |
| Schwartz RH, Voth EA, She... |
Marijuana to prevent nausea and vomiting in cancer patients: a survey ... |
South Med J |
1997 |
| Brauer RB, Heidecke CD, N... |
Liver transplantation for the treatment of fulminant hepatic failure i... |
Transpl Int |
1997 |
| Hussain, G. and Manyam, B... |
Mucuna pruriens Proves More Effective than L-DOPA in Parkinson's Disea... |
Phytotherapy Researc... |
1997 |
| Gallily R, Yamin A, Waksm... |
Protection against septic shock and suppression of tumor necrosis fact... |
J Pharmacol Exp Ther |
1997 |
| Andreu V, Mas A, Bruguera... |
Ecstasy: a common cause of severe acute hepatotoxicity |
J Hepatol |
1998 |
| Schwab M, Seyringer E, Br... |
Fatal MDMA intoxication |
Lancet |
1999 |
| Stein DJ, Rink J |
Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors |
J Clin Psychiatry |
1999 |
| Nagayama T, Sinor AD, Sim... |
Cannabinoids and neuroprotection in global and focal cerebral ischemia... |
J Neurosci |
1999 |
| McFee RB, Mofenson HC, Ca... |
Dextromethorphan: Another 'Ecstasy'? |
Arch Fam Med |
2000 |
| van Aerts LAGJM, Malleret... |
N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties ... |
Addiction Biology |
2000 |
| de la Torre R, Farré M, O... |
Non-linear pharmacokinetics of MDMA (`ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| de la Torre R, Farre M, O... |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| Bogenschutz MP |
Drug information libraries on the Internet |
J Psychoactive Drugs |
2000 |
| Borth S, Hänsel W, Rösner... |
Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their re... |
Forensic Sci Int |
2000 |
| Kavanagh P, Dunne J, Feel... |
Phenylalkylamine abuse among opiate addicts attending a methadone trea... |
Addict Biol |
2001 |
| Maldonado E, Navarro JF |
Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encoun... |
Pharmacological Rese... |
2001 |
| Pittler M, Edzard E |
Kava extract for treating anxiety (Cochrane Review) |
Cochrane Database Sy... |
2001 |
| de Boer D, Bosman IJ, Hid... |
Piperazine-like compounds: a new group of designer drugs-of-abuse on t... |
Forensic Sci Int |
2001 |
| van Zyl EF |
A survey of reported synthesis of methaqualone and some positional and... |
Forensic Sci Int |
2001 |
| Stuerenburg HJ, Petersen ... |
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and... |
Neuroendocrinol Lett |
2002 |
| Sheffler DJ, Roth BL |
Salvinorin A: the 'magic mint' hallucinogen finds a molecular target i... |
Trends Pharmacol Sci |
2003 |
| DEA Intelligence Division |
PCP: The Threat Remains |
Microgram |
2003 |
| Darlington CL |
Dexanabinol: A novel cannabinoid with neuroprotective properties |
IDrugs |
2003 |
| Halpern JH |
Hallucinogens: an update |
Curr Psychiatry Rep |
2003 |
| Jiang W, Zhang Y, Xiao L,... |
Cannabinoids promote embryonic and adult hippocampus neurogenesis and ... |
J Clin Invest |
2005 |
| Snyder SH |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Cochems A, Harding P, Lid... |
Dextromethorphan in Wisconsin drivers |
J Anal Toxicol |
2007 |
| Fucci N |
Unusual adulterants in cocaine seized on Italian clandestine market |
Forensic Sci Int |
2007 |
| Thorlacius K, Borna C, Pe... |
[Bromo-dragon fly--life-threatening drug: Can cause tissue necrosis as... |
Lakartidningen |
2008 |
| Brandt SD, Martins CP, Fr... |
N,N-Dimethyltryptamine and dichloromethane: rearrangement of quaternar... |
J Pharm Biomed Anal |
2008 |
| Linde K, Berner MM, Krist... |
St John's wort for major depression |
Cochrane Database of... |
2008 |
| Neukamm MA, Mürdter TE, W... |
Quantitative determination of the active ’Spice’ ingredient JWH-018 in... |
|
2008 |
| Wood DM, Button J, Lidder... |
Dissociative and sympathomimetic toxicity associated with recreational... |
J Med Toxicol |
2008 |
| Deluca P, Schifano F, Dav... |
Spice Report Psychonaut Web Mapping Research Project |
The Psychonaut Web M... |
2009 |
| Gryniewicz CM, Reepmeyer ... |
Detection of undeclared erectile dysfunction drugs and analogues in di... |
J Pharm Biomed Anal |
2009 |
| Auwärter V, Dresen S, Wei... |
'Spice' and other herbal blends: harmless incense or cannabinoid desig... |
Journal of Mass Spec... |
2009 |
| Mustata C, Torrens M, Par... |
[Spice drugs: cannabinoids as a new designer drugs] |
Adicciones |
2009 |
| Schifanoa F, Corazzaa O, ... |
Psychoactive drug or mystical incense? Overview of the online availabl... |
International Journa... |
2009 |
| Zimmermann US, Winkelmann... |
Withdrawal phenomena and dependence syndrome after the consumption of ... |
Dtsch Arztebl Int |
2009 |
| Ashton CH, Moore PB, Sum... |
Regulation of synthetic cannabinoids |
Lancet |
2009 |
| Schifano F, Ricciardi A, ... |
[New drugs and role of the web: Psychonaut Web Mapping Project] |
Riv Psichiatr |
2010 |
| Wood DM, Davies S, Puchna... |
Recreational Use of Mephedrone 4-Methylmethcathinone, 4-MMC with Assoc... |
J Med Toxicol |
2010 |
| Müller H, Sperling W, Köh... |
The synthetic cannabinoid Spice as a trigger for an acute exacerbation... |
Schizophr Res |
2010 |
| Uchiyama N, Kikura-Hanaji... |
Chemical analysis of synthetic cannabinoids as designer drugs in herba... |
Forensic Sci Int |
2010 |
| Gibbons S, Zloh M |
An analysis of the 'legal high' mephedrone |
Bioorg Med Chem Lett |
2010 |
| Hudson S, Ramsey J, King ... |
Use of high-resolution accurate mass spectrometry to detect reported a... |
J Anal Toxicol |
2010 |
| Lindigkeit R, Böhme A, Ei... |
Synthese, Charakterisierung und Analyse von JWH-018-StrukturanalogenSy... |
|
2010 |
| Wohlfarth A, Weinmann W |
Bioanalysis of new designer drugs |
|
2010 |
| Griffiths Pl, Sedefov R, ... |
How globalization and market innovation challenge how we think about a... |
Addiction |
2010 |
| Wood DM, Greene SL, Darga... |
Clinical pattern of toxicity associated with the novel synthetic cathi... |
Emerg Med J |
2010 |
| Dargan PI, Albert S, Wood... |
Mephedrone use and associated adverse effects in school and college/un... |
QJM |
2010 |
| Winstock AR, Mitcheson LR... |
Mephedrone, new kid for the chop? |
Addiction |
2010 |
| Bossong MG, Brunt TM, Van... |
mCPP: an undesired addition to the ecstasy market |
J Psychopharmacol |
2010 |
| Dresen S, Ferreirós N, Pü... |
Monitoring of herbal mixtures potentially containing synthetic cannabi... |
J Mass Spectrom |
2010 |
| Winstock A, Mitcheson L, ... |
Mephedrone: still available and twice the price |
Lancet |
2010 |
| Karila L, Reynaud M |
GHB and synthetic cathinones: clinical effects and potential consequen... |
Drug Test Anal |
2010 |
| McGaw C, Kankam O |
The Co-Ingestion of Alcohol and Mephedrone - an Emerging Cause of Acut... |
West London Medical ... |
2010 |
| Fattore L, Fratta W |
Beyond THC: the new generation of cannabinoid designer drugs |
Frontiers in Behavio... |
2011 |
| Nichols D |
Legal highs: the dark side of medicinal chemistry |
Nature |
2011 |
| McElrath K, O'Neill C |
Experiences with mephedrone pre- and post-legislative controls: Percep... |
Int J Drug Policy |
2011 |
| Every-Palmer S |
Synthetic cannabinoid JWH-018 and psychosis: An explorative study |
Drug Alcohol Depend |
2011 |
| Kikura-Hanajiri R, Uchiya... |
Survey of current trends in the abuse of psychotropic substances and p... |
Leg Med Tokyo |
2011 |
| Gatch MB, Forster MJ, Jan... |
Abuse Liability Profile of Three Substituted Tryptamines |
J Pharmacol Exp Ther |
2011 |
